Methods of using IL-1 antagonists to treat autoinflammatory disease

Details for Australian Patent Application No. 2011224099 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Yancopoulos, George D.; Mellis, Scott; Karow, Margaret; Papadopoulos, Joanne

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011224099

Parent 2005249570

Filing date 16 September 2011

Wipo publication date 17 November 2011

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

Event Publications

29 September 2011 Complete Application Filed

17 November 2011 Application Open to Public Inspection

  Published as AU-A-2011224099

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224100-Compact line locks and methods

2011224098-Extrusion process for making compositions with poorly compressible therapeutic compounds